vinorelbine tartrate
not tagged
['nsclc', 'vinorelbine', 'sclc', 'jipang']
dr kiyotaka yoh presents ph3 jipang trial of cis/pem vs vinorelbine/pem in resected stage ii/iii nsclc. importantly, 20-30% of pts experienced cns recurrence. hopefully emergence of io/targeted approaches will curb this. #esmo22 
Thoracic Medical Oncologist @lombardicancer, Assistant Professor @Georgetown. Interested in immunotherapy translational clinical trials. Opinions are my own.